Anbieter: Anybook.com, Lincoln, Vereinigtes Königreich
EUR 116,80
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,1050grams, ISBN:9781405112925.
EUR 189,25
Anzahl: 15 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 194,52
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
EUR 252,38
Anzahl: 3 verfügbar
In den WarenkorbZustand: New. pp. x + 319 Illus.
EUR 212,70
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Fatty liver disease, especially non--alcoholic steatohepatitis (NASH), is emerging as the most common form of liver disease -- affecting at least 5% of the population of western countries with increasing incidence in developing economies in other continents.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 294,88
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st edition. 336 pages. 10.00x7.75x1.00 inches. In Stock.
EUR 310,63
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Fatty liver disease, especially non--alcoholic steatohepatitis (NASH), is emerging as the most common form of liver disease -- affecting at least 5% of the population of western countries with increasing incidence in developing economies in other continents (particularly Asia, South America and South Africa). Editor(s): Farrell, Geoffrey C.; George, Jacob; Hall, Pauline de la M.; McCullough, Arthur J. Num Pages: 336 pages, 71 illustrations. BIC Classification: MJJ. Category: (P) Professional & Vocational. Dimension: 262 x 187 x 23. Weight in Grams: 806. . 2004. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.
Buch. Zustand: Neu. Neuware - Fatty liver disease, especially non-alcoholic steatohepatitis (NASH), is emerging as the most common form of liver disease - affecting at least 5% of the population of western countries with increasing incidence in developing economies in other continents (particularly Asia, South America and South Africa).